What is the main complication to monitor for when administering oxytocin to strengthen and coordinate contractions?

Oxytocin is a natural hormone that manages key aspects of the female and male reproductive systems, including labor and delivery and lactation, as well as aspects of human behavior. Your hypothalamus makes oxytocin, but your posterior pituitary gland stores and releases it into your bloodstream.

Hormones are chemicals that coordinate different functions in your body by carrying messages through your blood to your organs, muscles and other tissues. These signals tell your body what to do and when to do it.

Your hypothalamus is the part of your brain that controls functions like blood pressure, heart rate, body temperature and digestion.

Your pituitary gland is a small, pea-sized endocrine gland located at the base of your brain below your hypothalamus.

Synthetic forms of oxytocin

Healthcare providers use synthetic (manufactured) forms of oxytocin — Syntocinon® and Pitocin® — to induce labor in childbirth if it hasn’t started naturally or to strengthen contractions. Healthcare providers also use synthetic oxytocin to speed up delivery of the placenta (the third stage of labor) and reduce the risk of heavy bleeding (postpartum hemorrhage).

What is the function of oxytocin?

The two main physical functions of oxytocin are to stimulate uterine contractions in labor and childbirth and to stimulate contractions of breast tissue to aid in lactation after childbirth.

Oxytocin also acts as a chemical messenger in your brain and has an important role in many human behaviors and social interactions, including:

  • Sexual arousal.
  • Recognition.
  • Trust.
  • Romantic attachment.
  • Parent-infant bonding.

The effects of oxytocin on your brain are complex. Scientists are currently researching the role of oxytocin in various conditions, including:

Oxytocin and uterine contractions

During labor, when the fetus's body (usually head) pushes against your cervix, the nerve impulses from this stimulation travel to your brain and stimulate your pituitary gland to release oxytocin into your bloodstream. The oxytocin travels to your uterus and stimulates contractions.

These uterine contractions, in turn, cause your pituitary gland to release more oxytocin, leading to an increase in both the intensity and frequency of contractions. Oxytocin also increases the production of prostaglandins (a group of lipids with hormone-like actions), which move labor along and increase the contractions even more. This enables you to carry out vaginal delivery completely.

Oxytocin and lactation

Once your baby is born, oxytocin promotes lactation by causing contractions of the myoepithelial cells in the alveolar ducts of your breasts. These contractions move milk through your breast tissue.

When your baby sucks at your breast, oxytocin secretion causes the milk to release so your baby can feed. As long as your baby keeps sucking, your pituitary gland continues releasing oxytocin. Once your baby stops feeding, the release of oxytocin stops until the next feeding.

Oxytocin in people assigned male at birth

In people assigned male at birth (AMAB), oxytocin plays a part in ejaculation. The hormone contracts the vas deferens to push sperm and semen forward for ejection. Oxytocin also affects the production of testosterone (a sex hormone) in the testes.

How are oxytocin levels controlled?

Oxytocin is one of a few hormones that have a positive feedback loop. This means that the release of oxytocin leads to actions that stimulate your pituitary gland to release even more of it.

Most hormones create negative feedback loops after they’re released, meaning your body releases less of the hormone after it has its effect on your body.

With uterine contractions in childbirth, pressure on your cervix from the fetus baby stimulates your pituitary to release oxytocin. The release continues until your baby is born. With lactation and breastfeeding (chestfeeding), your baby’s sucking stimulates your pituitary to release oxytocin to push milk through your breast tissue. The release continues until your baby stops feeding and will restart when your baby feeds again.

What happens when oxytocin levels are low?

Having lower-than-normal levels of oxytocin is rare.

Low levels of oxytocin could stop uterine contractions during the birthing process and prevent milk ejection after giving birth. Although it’s rare, the most common cause of lower-than-normal oxytocin levels is panhypopituitarism, a condition in which all the levels of hormones your pituitary gland releases are below normal.

Low oxytocin levels have been linked to autism spectrum disorder and depressive symptoms. Scientists are still researching the connection between oxytocin and these conditions, and the potential of using synthetic oxytocin as a treatment.

What happens when oxytocin levels are high?

Having higher-than-normal oxytocin levels is very rare for people assigned female at birth (AFAB) and is called oxytocin toxicity. It results in an overactive uterus, causing an increase in uterine muscle mass (hypertrophy), which limits pregnancy due to not being enough space in your uterus to hold your fetus.

For people assigned male at birth, high levels of oxytocin have been linked to benign prostatic hyperplasia (BPH). BPH is a condition in which the prostate, a walnut-sized body part made of glandular and muscular tissue, grows in size.

The prostate surrounds part of the urethra, which is the tube that carries urine and sperm out of the body. BPH can make it difficult to pee (urinate). It affects more than half of people assigned male at birth over the age of 60.

As oxytocin is associated with trust, sexual arousal and relationship building, it’s sometimes referred to as the “love hormone” or “cuddle chemical.” Oxytocin levels also increase when you’re hugging someone and when you’re experiencing an orgasm.

A note from Cleveland Clinic

Oxytocin is an essential hormone for childbirth and lactation. While it’s rare to have abnormally high or low levels of oxytocin, your healthcare provider may recommend receiving a synthetic form of oxytocin to kick-start labor if you’re pregnant. This could be for a number of reasons and not necessarily because your body isn’t making or releasing enough of the hormone naturally. If you have any questions about labor and delivery and/or lactation, be sure to ask your healthcare provider. They’re available to help.

  1. Dale HH. The action of extracts of the pituitary body. Biochem J. 1909;4(9):427–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. du Vigneaud V, Ressler C, Trippett S. The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. J Biol Chem. 1953;205(2):949–57.

    CAS  Google Scholar 

  3. Wakerley JB, Poulain DA, Brown D. Comparison of firing patterns in oxytocin- and vasopressin-releasing neurones during progressive dehydration. Brain Res. 1978;148(2):425–40.

    Article  CAS  PubMed  Google Scholar 

  4. Uvnäs Moberg K. Oxytocin: the biological guide to motherhood. Amarillo: Praeclarus Press; 2014.

    Google Scholar 

  5. Sofroniew M. Morphology of vasopressin and oxytocin neurones and their central and vascular projections. Prog Brain Res. 1983;60:101–14.

    Article  CAS  PubMed  Google Scholar 

  6. Romano A, Tempesta B, Micioni Di Bonaventura MV, Gaetani S. From autism to eating disorders and more: the role of oxytocin in neuropsychiatric disorders. Front Neurosci. 2016;12(9):497.

    Google Scholar 

  7. Keverne EB. Central mechanisms underlying the neural and neuroendocrine determinants of maternal behaviour. Psychoneuroendocrinology. 1988;13(1):127–41.

    Article  CAS  PubMed  Google Scholar 

  8. World Health Organization (WHO). WHO recommendations for the prevention and treatment of postpartum haemorrhage. http://apps.who.int/iris/bitstream/10665/75411/1/9789241548502_eng.pdf?ua=1. Accessed Dec 2018.

  9. Clark SL, Simpson KR, Knox GE, Garite TJ. Oxytocin: new perspectives on an old drug. American journal of obstetrics and gynecology. Am J Obstet Gynecol. 2009;200(1):35–e1.

    Article  PubMed  CAS  Google Scholar 

  10. Gu V, Feeley N, Gold I, Hayton B, Robins S, Mackinnon A, Zelkowitz P. Intrapartum synthetic oxytocin and its effects on maternal well-being at 2 months postpartum. Birth. 2016;43(1):28–35.

    Article  PubMed  Google Scholar 

  11. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Uvnäs-Moberg K, Handlin L, Petersson M. Promises and pitfalls of hormone research in human–animal interaction. In: McCardle P, McCune S, Griffin J, Maholmes V, editors. How animals affect us Examining the influence of human-animal-interaction on child development and human health. Edn. Washington DC: American Psychological Association; 2011.

    Google Scholar 

  13. Coch JA, Brovetto J, Cabot HM, Fielitz CA, Caldeyro-Barcia R. Oxytocin-equivalent activity in the plasma of women in labor and during the puerperium. Am J Obstet Gynecol. 1965;91(1):10–7.

    Article  CAS  PubMed  Google Scholar 

  14. Kumaresan P, Anandarangam P, Dianzon W, Vasicka A. Plasma oxytocin levels during human pregnancy and labor as determined by radioimmunoassay. Am J Obstet Gynecol. 1974;119(2):215–23.

    Article  CAS  PubMed  Google Scholar 

  15. Kumaresan P, Han GS, Anandarangam PB, Vasicka A. Oxytocin in maternal and fetal blood. Obstet Gynecol. 1975;46(3):272–4.

    CAS  PubMed  Google Scholar 

  16. Gibbens GLD, Chard T. Observations on maternal oxytocin release during human labor and the effect of intravenous alcohol administration. Am J Obstet Gynecol. 1976;126(2):243–6.

    Article  CAS  PubMed  Google Scholar 

  17. Vasicka A, Kumaresan P, Han G, Kumaresan M. Plasma oxytocin in initiation of labor. Am J Obstet Gynecol. 1978;130(3):263–73.

    CAS  PubMed  Google Scholar 

  18. Dawood MY, Ylikorkola O, Triveda D. Oxytocin in maternal circulation and amniotic fluid during pregnancy*. J Clin Endocrinol Metab. 1979;49(3):429–34.

    Article  CAS  PubMed  Google Scholar 

  19. Leake RD, Weitzman RE, Glatz TH, Fisher DA. Plasma oxytocin concentrations in men, nonpregnant women, and pregnant women before and during spontaneous labor*. J Clin Endocrinol Metab. 1981;53(4):730–3.

    Article  CAS  PubMed  Google Scholar 

  20. Otsuki Y, Yamaji K, Fujita M, Takagi T, Tanizawa O. Serial plasma oxytocin levels during pregnancy and labor. Acta Obstet Gynecol Scand. 1983;62(1):15–8.

    Article  CAS  PubMed  Google Scholar 

  21. Goodfellow CF, Hull MGR, Swaab DF, Dogterom J, Buijs RM. Oxytocin deficiency at delivery with epidural analgesia. Br J Obstet Gynaecol. 1983;90(3):214–9.

    Article  CAS  PubMed  Google Scholar 

  22. Husslein P, Fuchs AR, Fuchs F. Oxytocin- and prostaglandin plasma concentrations before and after spontaneous labor: evidence of involvement of prostaglandins in the mechanism of placental separation. Wien Klin Wochenschr. 1983;95(11):367.

    CAS  PubMed  Google Scholar 

  23. Fuchs A-R, Goeschen K, Husslein P, Rasmussen AB, Fuchs F. Oxytocin and the initiation of human parturition: III. Plasma concentrations of oxytocin and 13, 14-dihydro-15-keto-prostaglandin F2α in spontaneous and oxytocin-induced labor at term. Am J Obstet Gynecol. 1983;147(5):497–502.

    Article  CAS  PubMed  Google Scholar 

  24. Amico JA, Seitchik J, Robinson AG. Studies of oxytocin in plasma of women during hypocontractile labor. J Clin Endocrinol Metab. 1984;58(2):274–9.

    Article  CAS  PubMed  Google Scholar 

  25. Takeda S, Kuwabara Y, Mizuno M. Effects of pregnancy and labor on oxytocin levels in human plasma and cerebrospinal fluid. Endocrinol Jpn. 1985;32(6):875–80.

    Article  CAS  PubMed  Google Scholar 

  26. Takagi T, Tanizawa O, Otsuki Y, Sugita N, Haruta M, Yamaji K. Oxytocin in the cerebrospinal fluid and plasma of pregnant and nonpregnant subjects. Horm Metab Res. 1985;17(6):308–10.

    Article  CAS  PubMed  Google Scholar 

  27. De Geest K, Thiery M, Piron-Possuyt G, Vanden Driessche R, Driessche RV. Plasma oxytocin in human pregnancy and parturition. J Perinat Med. 1985;13(1):3–13;14.

    Article  PubMed  Google Scholar 

  28. Kuwabara Y, Takeda S, Mizuno M, Sakamoto S. Oxytocin levels in maternal and fetal plasma, amniotic fluid, and neonatal plasma and urine. Arch Gynecol Obstet. 1987;241(1):13–23.

    Article  CAS  PubMed  Google Scholar 

  29. Thornton S, Davison JM, Baylis PH. Plasma oxytocin during third stage of labour: comparison of natural and active management. BMJ. 1988;297(6642):167–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Oosterbaan HP, Swaab DF. Amniotic oxytocin and vasopressin in relation to human fetal development and labour. Early Hum Dev. 1989;19(4):253–62.

    Article  CAS  PubMed  Google Scholar 

  31. Fuchs A-R, Romero R, Keefe D, Parra M, Oyarzun E, Behnke E. Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women. Am J Obstet Gynecol. 1991;165(5):1515–23.

    Article  CAS  PubMed  Google Scholar 

  32. Stocche RM, Klamt JG, Antunes-Rodrigues J, Garcia LV, Moreira AC. Effects of intrathecal sufentanil on plasma oxytocin and cortisol concentrations in women during the first stage of labor. Reg Anesth Pain Med. 2001;26(6):545–50.

    Article  CAS  PubMed  Google Scholar 

  33. Szeto A, McCabe PM, Nation DA, Tabak BA, Rossetti MA, McCullough ME, Schneiderman N, Mendez AJ. Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom Med. 2011;73(5):393.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Levine A, Zagoory-Sharon O, Feldman R, Weller A. Oxytocin during pregnancy and early postpartum: individual patterns and maternal–fetal attachment. Peptides. 2007;28(6):1162–9.

    Article  CAS  PubMed  Google Scholar 

  35. Leng G, Sabatier N. Measuring oxytocin and vasopressin: bioassays, immunoassays and random numbers. J Neuroendocrinol. 2016;28(10).

  36. Fergusson JKW. A study of the motility of the intact uterus at term. Surg Gynecol Obstet. 1941;73:359–66.

    Google Scholar 

  37. Fuchs A-R, Fuchs F, Husslein P, Soloff MS. Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol. 1984;150(6):734–41.

    Article  CAS  PubMed  Google Scholar 

  38. Sato Y, Hotta H, Nakayama H, Suzuki H. Sympathetic and parasympathetic regulation of the uterine blood flow and contraction in the rat. J Auton Nerv Syst. 1996;59(3):151–8.

    Article  PubMed  Google Scholar 

  39. Puder BA, Papka RE. Hypothalamic paraventricular axons projecting to the female rat lumbosacral spinal cord contain oxytocin immunoreactivity. J Neurosci Res. 2001;64(1):53–60.

    Article  CAS  PubMed  Google Scholar 

  40. Jones P, Robinson I. Differential clearance of neurophysin and neurohypophysial peptides from the cerebrospinal fluid in conscious Guinea pigs. Neuroendocrinology. 1982;34(4):297–302.

    Article  CAS  PubMed  Google Scholar 

  41. Ludwig M, Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci. 2006;7(2):126–36.

    Article  CAS  PubMed  Google Scholar 

  42. Knobloch HS, Charlet A, Hoffmann LC, Eliava M, Khrulev S, Cetin AH, Osten P, Schwarz MK, Seeburg PH, Stoop R. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron. 2012;73(3):553–66.

    Article  CAS  PubMed  Google Scholar 

  43. Waldenström U, Irestedt L. Obstetric pain relief and its association with remembrance of labor pain at two months and one year after birth. J Psychosom Obstet Gynecol. 2006;27(3):147–56.

    Article  Google Scholar 

  44. Buckley SJ. Hormonal physiology of childbearing: evidence and implications for women, babies, and maternity care. Washington: Childbirth; 2015.

    Google Scholar 

  45. Olza I, Leahy-Warren P, Benyamini Y, Kazmierczak M, Karlsdottir SI, Spyridou A, et al. Women’s psychological experiences of physiological childbirth: a meta-synthesis. (2044–6055 (Electronic)).

  46. Velandia M, Matthisen AS, Uvnäs-Moberg K, Nissen E. Onset of vocal interaction between parents and newborns in skin-to-skin contact immediately after elective cesarean section. Birth. 2010;37(3):192–201.

    Article  PubMed  Google Scholar 

  47. Bystrova K, Matthiesen AS, Vorontsov I, Widström AM, Ransjö-Arvidson AB, Uvnäs-Moberg K. Maternal axillar and breast temperature after giving birth: effects of delivery ward practices and relation to infant temperature. Birth. 2007;34(4):291–300.

    Article  PubMed  Google Scholar 

  48. Budden A, Chen LJ, Henry A. High-dose versus low-dose oxytocin infusion regimens for induction of labour at term. Cochrane Database Syst Rev. 2014(10):Cd009701.

  49. Phaneuf S, Rodriguez Linares B, TambyRaja RL, MacKenzie IZ. Lopez Bernal a: loss of myometrial oxytocin receptors during oxytocin-induced and oxytocin-augmented labour. J Reprod Fertil. 2000;120(1):91–7.

    Article  CAS  PubMed  Google Scholar 

  50. Grotegut CA, Paglia MJ, Johnson LN, Thames B, James AH. Oxytocin exposure during labor among women with postpartum hemorrhage secondary to uterine atony. Am J Obstet Gynecol. 2011;204(1):56.e51–6.

    Google Scholar 

  51. Wiberg-Itzel E, Pettersson H, Andolf E, Hansson A, Winbladh B, Akerud H. Lactate concentration in amniotic fluid: a good predictor of labor outcome. Eur J Obstet Gynecol Reprod Biol. 2010;152(1):34–8.

    Article  CAS  PubMed  Google Scholar 

  52. Nielsen EI, Al-Saqi SH, Jonasson AF, Uvnas-Moberg K. Population pharmacokinetic analysis of vaginally and intravenously administered oxytocin in postmenopausal women. J Clin Pharmacol. 2017;57(12):1573–81.

    Article  CAS  PubMed  Google Scholar 

  53. Titus MA, Reynolds DR, Glendening MB, Page EW. Plasma aminopeptidase activity (oxytocinase) in pregnancy and labor. Am J Obstet Gynecol. 1960;80:1124–8.

    Article  CAS  PubMed  Google Scholar 

  54. Randolph GW, Fuchs A-R. Pulsatile administration enhances the effect and reduces the dose of oxytocin required for induction of labor. Am J Perinatol. 1989;6(02):159–66.

    Article  CAS  PubMed  Google Scholar 

  55. Willcourt RJ, Pager D, Wendel J, Hale RW. Induction of labor with pulsatile oxytocin by a computer-controlled pump. Am J Obstet Gynecol. 1994;170(2):603–8.

    Article  CAS  PubMed  Google Scholar 

  56. Dawood MY. Evolving concepts of oxytocin for induction of labor. Am J Perinatol. 1989;6(2):167–72.

    Article  CAS  PubMed  Google Scholar 

  57. Liu J, Yi Y, Weiwei X. Effects of increased frequency, high dose, and pulsatile oxytocin regimens on abnormal labor delivery. Med Sci Monit. 2018;24:2063–71.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Tribe RM, Crawshaw SE, Seed P, Shennan AH, Baker PN. Pulsatile versus continuous administration of oxytocin for induction and augmentation of labor: two randomized controlled trials. Am J Obstet Gynecol. 2012;206(3):230.e231–8.

    Article  CAS  Google Scholar 

  59. Cummiskey KC, Gall SA, Dawood MY. Pulsatile administration of oxytocin for augmentation of labor. Obstet Gynecol. 1989;74(6):869–72.

    CAS  PubMed  Google Scholar 

  60. Salamalekis E, Vitoratos N, Kassanos D, Loghis C, Panayotopoulos N, Sykiotis C. A randomized trial of pulsatile vs continuous oxytocin infusion for labor induction. Clin Exp Obstet Gynecol. 2000;27(1):21–3.

    CAS  PubMed  Google Scholar 

  61. Odem RR, Work BA Jr, Dawood MY. Pulsatile oxytocin for induction of labor: a randomized prospective controlled study. J Perinat Med. 1988;16(1):31–7.

    Article  CAS  PubMed  Google Scholar 

  62. Talati C, Carvalho JC, Luca A, Balki M. The effect of intermittent oxytocin pretreatment on oxytocin-induced contractility of human myometrium in vitro. Anesth Analg. 2019;128(4):671–8.

    Article  CAS  PubMed  Google Scholar 


Page 2

Skip to main content

From: Maternal plasma levels of oxytocin during physiological childbirth – a systematic review with implications for uterine contractions and central actions of oxytocin

Conversion of different size units:
 1 Unit (IU) = 1000 milliunits (mU) = 1000,000 microunits (μU)
 1 g (g) = 1000 mg (mg) = 1000,000 micrograms (μg) = 1000,000,000 nanograms (ng) = 1000,000,000,000 picograms (pg)
 1 Mol/L = 1 Molar (M) = 1000 milliMolar (mM) = 1000,000 microMolar (μM) = 1000,000,000 nanoMolar (nM) = 1000,000,000,000 picoMolar (pM)
Conversion of units (U) to weight units:
 1 IU = 1.67 μg, 1 μg = 0.60 U
 1 mU = 1.67 ng, 1 ng = 0.60 mU
 1 μU = 1.67 pg, 1 pg = 0.60 μU
Conversion of weight/volume of oxytocin to Molarity
(molecular weight of oxytocin equal to 1007 g/mol):
 1 g/mL = 1 mol/L = 1 M
 1 mg/mL = 1 mmol/L = 1 mM
 1 μg /mL = 1 μmol/L = 1 μM
 1 ng/mL = 1 nmol/L = 1 nM
 1 pg/mL = 1 pmol/L = 1pM